Granules India (NSE:GRANULES) Days Sales Outstanding : 76.51 (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Granules India Days Sales Outstanding?

Granules India's average Accounts Receivable for the three months ended in Mar. 2024 was ₹9,858 Mil. Granules India's Revenue for the three months ended in Mar. 2024 was ₹11,758 Mil. Hence, Granules India's Days Sales Outstanding for the three months ended in Mar. 2024 was 76.51.

The historical rank and industry rank for Granules India's Days Sales Outstanding or its related term are showing as below:

NSE:GRANULES' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.08 Med: 89.27 Max: 116.78
Current: 79.65

During the past 13 years, Granules India's highest Days Sales Outstanding was 116.78. The lowest was 66.08. And the median was 89.27.

NSE:GRANULES's Days Sales Outstanding is ranked worse than
58.02% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs NSE:GRANULES: 79.65

Granules India's Days Sales Outstanding increased from Mar. 2023 (72.40) to Mar. 2024 (76.51).

Granules India Days Sales Outstanding Historical Data

The historical data trend for Granules India's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Days Sales Outstanding Chart

Granules India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

95.76

81.51

82.77

75.78

78.34

Granules India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															72.40	87.83	77.92	80.21	76.51

Competitive Comparison of Granules India's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Granules India's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Granules India's Days Sales Outstanding falls into.

Granules India Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Granules India's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (9485.42	+	9858.33)	/	2 )	/	45063.67	*	365
=	9671.875					/	45063.67	*	365
=	78.34

Granules India's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	9858.33)	/	1 )	/	11757.79	*	365 / 4
=	9858.33					/	11757.79	*	365 / 4
=	76.51

Granules India (NSE:GRANULES) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Granules India Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Granules India's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Granules India (NSE:GRANULES) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

532482:India

Address

3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081

Website

https://www.granulesindia.com

Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines